Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantORIENT EUROPHARMA PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INFUSION, SOLUTION CONCENTRATE
INTRAVENOUS
Medical Information
A16AB20
Manufacturer Information
ORIENT EUROPHARMA PTE LTD
Chiesi Farmaceutici S.p.A.
Active Ingredients
Documents
Package Inserts
Elfabrio Concentrate for Solution for Infusion PI.pdf
Approved: February 20, 2025